nicotine has been researched along with aristolochic acid i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Kanfer, JN; Singh, IN; Sitar, DS; Sorrentino, G | 1 |
2 other study(ies) available for nicotine and aristolochic acid i
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
(-)Nicotine inhibits the activations of phospholipases A2 and D by amyloid beta peptide.
Topics: Acetophenones; Amyloid beta-Peptides; Arachidonic Acids; Aristolochic Acids; Brain; Brain Chemistry; Cells, Cultured; Cotinine; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Hexamethonium; Kainic Acid; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phenanthrenes; Phospholipase D; Phospholipases A; Phospholipases A2; Quisqualic Acid; Tubocurarine; Type C Phospholipases | 1998 |